Abstract:
A process and a preparation plant prepares methacrolein from formaldehyde and propionaldehyde, in presence of water and a homogeneous catalyst based at least on an acid and a base. A reaction mixture is introduced into a methacrolein workup plant and separated in a first distillation column, into a first distillation mixture in a gas phase at the top and a second distillation mixture in a liquid phase at the bottom. The first distillation mixture is condensed and, in a first phase separator, the organic phase and the aqueous phase of the condensate are separated from one another. The aqueous phase is introduced into a second distillation column, that is not part of the methacrolein workup plant, and is separated into a third distillation mixture in a gas phase at the top and a fourth distillation mixture at the bottom. The third distillation mixture is introduced into the methacrolein workup plant.
Abstract:
Processes and systems for separating a mixture of three or more chemical components into multiple product streams each enriched in one of the components are provided herein. In some aspects, the present invention relates to processes for the separation of a chemical mixture including at least a heavy key component, an intermediate key component, and a light key component to form a product stream enriched in the light key component, a product stream enriched in the intermediate key component, and a product stream enriched in the heavy key component. Systems described herein may include one or more thermally coupled distillation columns including, for example, a dividing wall column, or a plurality of distillation columns arranged in a thermally integrated configuration.
Abstract:
The present invention provides a method for concentrating an aqueous solution containing at least 3-hydroxy-2,2-dimethyl propanal and/or a dimer thereof, which includes subjecting a mixed solution of an aqueous solution containing at least 3-hydroxy-2,2-dimethyl propanal and/or a dimer thereof and an azeotropic agent to azeotropic distillation in a distillation column to distil off water and the azeotropic agent from the mixed solution, wherein the mixed solution is prepared by adding, as the azeotropic agent, at least one selected from the group consisting of 1-butanol, 2-butanol, 2-methyl-1-propanol, 1-pentanol and 1-hexanol to the aqueous solution.
Abstract:
A method of producing acetaldehyde hydrogenates acetic acid in the presence of an iron oxide catalyst containing between 2.5 and 90 wt % Pd, more preferably 10 and 80 wt % Pd and most preferably 20 and 60 wt % Pd. The catalyst has a specific surface area of less than 150 m.sup.2 /g. Hydrogen and acetic acid are fed to a reactor in a hydrogen to acetic acid ratio of 2:1 to 25:1, more preferably in a hydrogen to acetic acid ratio of 3:1 to 15:1 and most preferably in a hydrogen to acetic acid ratio of 4:1 to 12:1. The hydrogenation is performed at a temperature of about 250.degree. C. to 400.degree. C., more preferably about 270.degree. C. to 350.degree. C. and most preferably about 280.degree. C. to 325.degree. C. The hydrogenation of acetic acid produces a partially gaseous product, and acetaldehyde is absorbed from the partially gaseous product with a solvent containing acetic acid. The gas remaining after the absorption step contains hydrogen, and this gas is recycled for the hydrogenation of acetic acid. The absorbed acetaldehyde is distilled to isolate same. After acetaldehyde is isolated from unreacted acetic acid and the other products via distillation, the unreacted acetic acid is separated from the other products using azeotropic distillation. Water is contained in the other products, and the azeotrope is an azeotrope of ethyl acetate and water. The unreacted acetic acid is separated in a column, and the column is controlled to contain an ethyl acetate rich azeotrope of ethyl acetate and water.
Abstract:
The invention relates to a process for the preparation of fluorinated compoundsAz.sub.x ArF.sub.w Cl.sub.(y-w) R.sub.z (1)in which Az is a radical --F, --Cl, --Br, --NO.sub.2, --CN, --CF.sub.3, --CCl.sub.3, --CHO, --CO(C.sub.n H.sub.2n+1), --COX or --SO.sub.2 X, where X is F, Cl or Br, x is an integer from 1 to 3, Ar is a phenyl radical, pyridyl radical or naphthyl, w is an integer from 1 to y, y is an integer from 1 to 5, R is H, an alkyl radical or an alkoxy radical having from 1 to 10 carbon atoms, z is an integer from 1 to 5, (x+y+z) is the number of all substitutable valences on the radical Ar, which comprises reacting a compoundAz.sub.x ArCl.sub.y R.sub.z (2),with an alkali metal fluoride in the presence of a component a) or a mixture of component a) and at least one of components b), c), d) and/or e), component a) being one or more quaternary ammonium compounds which contain one or more radicals --(C.sub.m H.sub.2m O)R.sup.5, component b) being an amidophosphonium salt, component c) being a quaternary ammonium salt, component d) being a quaternary phosphonium salt, component e) being a polyether, and carrying out the reaction at from 50 to 250.degree. C., removing the compound of the formula (1) formed during the reaction by distillation, and the compound of the formula (2) is fed to the reaction mixture at a rate corresponding to the rate at which the compound of the formula (1) is removed.
Abstract:
Vanillin is difficult to separate from second organic chemicals produced therewith such as parahydroxybenzaldehyde by conventional distillation or rectification because of the proximity of their boiling points. Vanillin can now be readily separated from such second organic chemicals by azeotropic distillation using as an effective azeotropic distillation agent, dibenzyl ether.
Abstract:
The present invention relates to a novel and efficient process for the preparation of 8-hydroxybicyclo[7.3.1]tridec-4-ene-2,6-diyne ring system which is part of the aglycone of esperemicin and to novel cytotoxic antitumor agents having said bicyclic ring system. The present invention also provides a method for treating mammalian malignant tumors by administering to an animal in need of such treatment an antitumor effective amount of a compound of the present invention.
Abstract:
A process for separating, by distillation, a mixture consisting essentially of 3,3-dimethylacrolein and 3-methyl-3-buten-1-ol, wherein the mixture to be separated is distilled in the presence of water and glycerol, the 3,3-dimethyl-acrolein first being distilled off azeotropically with water and the 3-methyl-3-buten1-ol then being separated, as an azeotropic mixture with water, from the higher-boiling glycerol. It is also possible to isolate the 3,3-dimethylacrolein by distillation if the 3-methyl-3-buten1-ol is partially replaced by 3-methyl-2-buten-1-ol. The 3,3dimethylacrolein, which can be isolated in pure form by the process of the invention, is a valuable intermediate for the synthesis of natural substances such as citral, vitamin A and chrysanthemic acid.